These results suggest that CTRP3 maintained the barrier function of iBRB in DR by preventing the diabetes-induced Occludin and Claudin-5/tight junctions protein disruption, via AMPK-dependent signaling. This evidence concerns the gene OCLN and diabetes mellitus.